In a phase I study by Rudman et al. [182], an immunocytokine AS1409 targeting extra-domain B (ED-B) fibronectin isoform was used to deliver IL-12 into tumor mass in a small group of 13 patients with melanoma and renal cell carcinoma. Here, FN1 is linked to neoplasm.